Editorial: Extracellular Matrix Biomarkers Illuminate the Architecture of Portal Hypertension in End-Stage Liver Disease-Authors' Reply

Aliment Pharmacol Ther. 2025 Dec 21. doi: 10.1111/apt.70499. Online ahead of print.

Mattias Mandorfer^{1

2

3}, Benedikt Simbrunner^{1

2

3

4}, Diana Julie Leeming⁵

¹ Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
² Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
³ Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria.
⁴ CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
⁵ Nordic Bioscience, Herlev, Denmark.

No abstract available

Publication types